Target Volume Determination 2015

PET: Glucose Metabolism

DWI with background suppression: Multiple myeloma

CT/PET hybrid system

pre therapy SUV 10,2

After 2nd cycle SUV 5,7

Multiple myeloma post chemotherapy

Take home: Functional imaging • Information beyond anatomy – Movement – Microstructure – Biology • Ready to use: – Movement analysis • Needs evidence basis in RTX planning: – Spectroscopy – PET – Dynamic MRI and DWI – Diffusion-weighted imaging • Music of the future: – Diffusion tensor imaging for RTX planning

s.delorme@dkfz.de, Radiologie – E010, Innovative Krebsdiagnostik und -therapie